TITLE:
Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0653, ezetimibe / Duration of Treatment: 28 weeks

SUMMARY:

      The purpose of this study is to determine whether an investigational medication will be more
      effective than an approved medication in reducing cholesterol levels.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 79 Years
Criteria:

        Inclusion Criteria:

          -  Elevated cholesterol levels

        Exclusion Criteria:

          -  Liver disease

          -  Unstable medical conditions
      
